课题基金 / 基金详情

Forkhead Box A3 and Bile Acid Metabolism

Forkhead Box A3 and Bile Acid Metabolism
叉头盒 A3 和胆汁酸代谢
批准号:
9900348
负责人:
Yanqiao Zhang
金额:
$53.56万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-02-01 至 2024-01-31

项目摘要

项目成果

Yanqiao Zhang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Project Summary: Bile acids (BAs) are synthesized from cholesterol. BA synthesis is tightly controlled to prevent incidence of diseases, such as cholestasis, gallstone disease, malabsorption, hypercholesterolemia, etc. BAs are important for nutrient absorption and also function as endocrine hormones to regulate metabolic homeostasis. BAs can activate farnesoid X receptor (FXR) and TGR5 to prevent non-alcoholic fatty liver disease (NAFLD), diabetes and obesity. NAFLD is one of the most common chronic liver diseases worldwide, and is often associated with obesity and diabetes. Forkhead box protein A3 (FOXA3) is a transcription factor. So far, the role of hepatic FOXA3 in BA metabolism is completely unknown. Using both gain- and loss-of-function approaches, we show that FOXA3 is regulated by FXR and may regulate BA metabolism and metabolic homeostasis. In this project, we plan to investigate the role of hepatic FOXA3 in feedback regulation of BA metabolism and the role of BA signaling in FOXA3-regulated metabolic homeostasis. We will use a number of genetically modified mice as well as gain-of-function approaches to accomplish our goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Forkhead Box A3 and Bile Acid Metabolism
Forkhead Box A3 and Bile Acid Metabolism
Forkhead Box A3 and Bile Acid Metabolism
Hepatic FOXA3 Links NAFLD to Atherosclerosis
海外基金